Gerard, Melanie <br/><br/>
Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Feb 2010 
 - 2454-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Standard No.: </label>10.1523/JNEUROSCI.5983-09.2010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Animals<br/>Apoptosis--drug effects<br/>Cells, Cultured<br/>Corpus Striatum--metabolism<br/>Disease Models, Animal<br/>Humans<br/>Indoles<br/>Intermediate Filament Proteins--genetics<br/>Luciferases--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Mutation--genetics<br/>Nerve Degeneration--drug therapy<br/>Neuroblastoma--pathology<br/>Parkinson Disease--genetics<br/>RNA, Small Interfering--pharmacology<br/>Tacrolimus Binding Protein 1A--deficiency<br/>Tacrolimus Binding Proteins--antagonists & inhibitors<br/>Time Factors<br/>Transfection<br/>alpha-Synuclein--antagonists & inhibitors